Michael Harris Nathanson, MD, PhD

Gladys Phillips Crofoot Professor of Medicine (Digestive Diseases) and Professor of Cell Biology; Section Chief, Digestive Diseases; Director, Yale Liver Center; Director, Center for Cell and Molecular Imaging

Research Organizations

Cancer Center, Yale

Cell Biology: Membrane Traffic

Internal Medicine: Digestive Diseases

Research Summary

My laboratory studies the mechanisms and effects of calcium signals in polarized epithelia. One aspect of our work is to define how calcium signals are
differentially regulated in the nucleus and cytoplasm. This involves identification of distinct calcium stores and release mechanisms in the nucleus, and we are
examining whether and how these are activated selectively by growth factors. The second aspect of our work is to examine how calcium waves and other calcium signals regulate secretion in polarized epithelia. Calcium waves preferentially begin in, the apical region of most secretory epithelia, and we are in the process of defining the mechanisms responsible for this. We also are using an adenoviral antisense approach to understand the relative roles of each IP3 receptor isoform in regulating calcium signaling and secretion in vitro and in vivo. Another major focus is to examine intercellular communication of second messenger signals and to establish the mechanism by which gap junctions act in coordinating intercellular spread of Ca2+ waves in isolated pairs and triplets of cells.

Extensive Research Description

  • NIH P01 DK57751 (PI: M.H. Nathanson). Regulation of liver by nuclear calcium signaling. Duration: 4/1/06-3/31/11. The major goals of this project are to determine the mechanisms by which calcium is regulated in the nucleus of hepatocytes, and to determine the functional effects of nuclear calcium signals in liver.
  • NIH R01 DK45710 (PI: M.H. Nathanson). Calcium waves in hepatocytes: mechanisms and effects. Duration: 4/1/10-3/31/15. The major goals of this project are to determine the subcellular location and function of the different InsP3 receptor isoforms in hepatocytes and to determine if the different isoforms exert distinct effects on organization of calcium waves and regulation of secretion by calcium.
  • NIH R01 DK61747 (PI: B.E. Ehrlich, M.H. Nathanson [multiple PI’s] ). Regulation of cholangiocytes by InsP3 receptor isoforms. Duration: 5/1/09-4/30/13. Dr. Nathanson is co-investigator on this award. The major goals of this project are to determine how InsP3 receptors regulate calcium signaling and bicarbonate secretion in intrahepatic bile ducts.

Selected Publications

Edit this profile

Contact Info

Michael Harris Nathanson, MD, PhD
Patient Care Locations
Bridgeport Hospital-226 Mill Hill Avenue
226 Mill Hill Avenue

Bridgeport, CT 06610
Laboratory for Medicine and Pediatrics
15 York Street

New Haven, CT 06510
Yale-New Haven Hospital
20 York Street

New Haven, CT 06510
Mailing Address
PO Box 208019
New Haven, CT 06520-8019

Curriculum Vitae